Clinical Data ASCO26: In vivo CAR-Ts in the spotlight PharmaphorumData at ASCO on in vivo CAR-Ts from Kelonia and Legend add to the excitement about the emerging therapy class in both blood cancers and solid tumours.OncologyRead full story pharminent June 3, 2026 (Last updated: June 4, 2026) Pharmaphorum Data at ASCO on in vivo CAR-Ts from Kelonia and Legend add to the excitement about the emerging therapy class in both blood cancers and solid tumours. Oncology Read full story Post navigation Previous: Eli Lilly issues data sharing ultimatum to 340B hospitalsNext: AbbVie receives EC approval for Aquipta to treat migraine Related Stories Clinical Data Novartis hit as Lp(a) drug fails cardio outcomes trial pharminent September 7, 2026 Clinical Data Major trial of Roche Alzheimer’s drug kicks off in Europe pharminent September 7, 2026 Clinical Data AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma study pharminent September 4, 2026